Atlas Trials

A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

Clinical trial NCT07219043 · RECRUITING

Trial details

NCT number
NCT07219043
Sponsor
Biogen
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Microvascular Inflammation
Start date
2026-01-05
Primary completion
2028-02-10
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.